KIB OpenIR  > 离退休
Cytotoxic pentacyclic triterpenoids from the rhizome of Astilbe chinensis
Hongxiang Sun; Jianxin Zhang; Yiping Ye; Yuanjiang Pan; Yueao Shen
通讯作者panyuanjiang@css.zju.edu.cn
2003
发表期刊HELVETICA CHIMICA ACTA
ISSN0018-019X
卷号86期号:7页码:2414-2423
摘要Guided by in vitro antineoplastic tests, four cytotoxic pentacyclic triterpenoids, 3beta-hydroxyolean-12-en-27-oic acid (1), 3beta-hydroxyurs-12-en-27-oic acid (2), 3beta,6beta-dihydroxyolean-12-en-27-oic acid (3), and 3beta-acetoxyolean-12-en-27-oic acid (4) were isolated from the rhizome of Astilbe chinensis. Their structures were determined on the basis of chemical evidence and extensive spectroscopic methods including one-dimensional and two-dimensional NMR. These compounds showed cytotoxic activities against HO-8910, Hela and HL60 cell lines. In addition, beta-sitosterol palmitate, daucosterol, and beta-sitosterol have also been isolated.
学科领域Chemistry, Multidisciplinary
收录类别SCI ; IC
语种英语
WOS记录号WOS:000184797400010
引用统计
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/13475
专题离退休
推荐引用方式
GB/T 7714
Hongxiang Sun,Jianxin Zhang,Yiping Ye,et al. Cytotoxic pentacyclic triterpenoids from the rhizome of Astilbe chinensis[J]. HELVETICA CHIMICA ACTA,2003,86(7):2414-2423.
APA Hongxiang Sun,Jianxin Zhang,Yiping Ye,Yuanjiang Pan,&Yueao Shen.(2003).Cytotoxic pentacyclic triterpenoids from the rhizome of Astilbe chinensis.HELVETICA CHIMICA ACTA,86(7),2414-2423.
MLA Hongxiang Sun,et al."Cytotoxic pentacyclic triterpenoids from the rhizome of Astilbe chinensis".HELVETICA CHIMICA ACTA 86.7(2003):2414-2423.
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
Cytotoxic Pentacycli(100KB)期刊论文作者接受稿开放获取CC BY-NC-SA浏览 下载
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Hongxiang Sun]的文章
[Jianxin Zhang]的文章
[Yiping Ye]的文章
百度学术
百度学术中相似的文章
[Hongxiang Sun]的文章
[Jianxin Zhang]的文章
[Yiping Ye]的文章
必应学术
必应学术中相似的文章
[Hongxiang Sun]的文章
[Jianxin Zhang]的文章
[Yiping Ye]的文章
相关权益政策
暂无数据
收藏/分享
文件名: Cytotoxic Pentacyclic Triterpenoids from the Rhizome of Astilbe chinensis.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。